Dentons wins four awards at the MF Legal Rankings 2023May 15, 2023Dentons was honored with four awards at Class Editori’s “MF Legal Rankings 2023.”
Dentons wins four awards at TopLegal Industry Awards 2022May 13, 2022Dentons was awarded “Law Firm of the year—Life Sciences” and “Law Firm of the year—Technology,” while Italy Managing Partner Federico Sutti was named “Lawyer of the year—Real Estate” and Partner Giangiacomo Olivi was named “Lawyer of the year—Media” at the TopLegal Industry Awards 2022. This year, the awards ceremony took place in Milan on May 10, 2022.
Dentons named Financial & Corporate Firm of the Year: Corporate at the 2020 LMG European Life Sciences AwardsJune 11, 2020We are pleased to announce that the 2020 LMG European Life Sciences recognized Dentons as the winner in the Financial & Corporate Firm of the Year: Corporate category.
Ukraine introduces new benefits for voluntary tax complianceSeptember 30, 2024Ukraine: Commencing from October 1, 2024, tax benefits for taxpayers with a high level of voluntary tax compliance or members of the announced “White Business Club” will come into full force and effect.
Life Sciences Legal Update - Q1 2024March 27, 2024Czech Republic: We bring you the first 2024 edition of the quarterly Life Science Legal Update, in which we regularly cover key legal aspects and innovations in the Pharmaceuticals and Life Sciences sectors. The first quarter of 2024 is full of news in the pharmaceutical, healthcare services and food sectors. For instance, there has been much discussion about limiting the availability of HHC substances to consumers; in addition, several implementing regulations for the amendment to the Medicines Act have come into force as well as a new pricing regulation under which health insurers will now be able to request a maximum price for a specific medicinal product as part of an exceptional reimbursement regime. The EU is about to negotiate the draft pharmaceutical package presented by the European Commission. Last but not least, the major amendment to the Significant Market Power Act which has been newly effected, and which largely affects buyer-supplier relationships in the supply of food, agricultural products and other related services.
Life Sciences Legal Update - Q1 2024 (Czech)March 27, 2024Czech Republic: We bring you the first 2024 edition of the quarterly Life Science Legal Update, in which we regularly cover key legal aspects and innovations in the Pharmaceuticals and Life Sciences sectors. The first quarter of 2024 is full of news in the pharmaceutical, healthcare services and food sectors. For instance, there has been much discussion about limiting the availability of HHC substances to consumers; in addition, several implementing regulations for the amendment to the Medicines Act have come into force as well as a new pricing regulation under which health insurers will now be able to request a maximum price for a specific medicinal product as part of an exceptional reimbursement regime. The EU is about to negotiate the draft pharmaceutical package presented by the European Commission. Last but not least, the major amendment to the Significant Market Power Act which has been newly effected, and which largely affects buyer-supplier relationships in the supply of food, agricultural products and other related services.
Dentons releases Global AI Trends ReportJanuary 20, 2025Dentons, the world’s largest global law firm, has published a Global AI Trends report, highlighting key risk considerations with viewpoints from multiple jurisdictions.
Dentons advises Reģionālā investīciju banka on financing of Farmak’s new plant in SpainJune 17, 2024Dentons advised Latvian commercial bank Reģionālā investīciju banka (RIB) on its financing of Farmak, Ukraine’s leading pharmaceutical company. The transaction marks RIB’s entrance to the Spanish market.
Dentons and EURORDIS form pro bono allianceJanuary 10, 2024Global law firm Dentons has concluded an agreement to provide EURORDIS-Rare Diseases Europe with pro bono legal services.